Leap Therapeutics Inc
NASDAQ:LPTX
Leap Therapeutics Inc
NASDAQ:LPTX
Price:
3.22 USD
0.94%
Market Closed
Updated:
May 7, 2024
Leap Therapeutics Inc
Cash from Investing Activities
|
Leap Therapeutics Inc
Cash from Investing Activities Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Leap Therapeutics Inc
NASDAQ:LPTX
|
Cash from Investing Activities
$49m
|
CAGR 3-Years
1 077%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Cash from Investing Activities
-$2B
|
CAGR 3-Years
62%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash from Investing Activities
-$2.3B
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-76%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Investing Activities
-$26.2B
|
CAGR 3-Years
-69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash from Investing Activities
-$3.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-73%
|
CAGR 10-Years
-50%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash from Investing Activities
-$3.2B
|
CAGR 3-Years
-256%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-25%
|
See Also
What is Leap Therapeutics Inc's Cash from Investing Activities?
Cash from Investing Activities
49m
USD
49m
USD
Based on the financial report for Dec 31, 2023, Leap Therapeutics Inc's Cash from Investing Activities amounts to 49m USD.
What is Leap Therapeutics Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
1 077%
1 077%
The average annual Cash from Investing Activities growth rates for Leap Therapeutics Inc have been 1 077% over the past three years .
You don't have any saved screeners yet
